Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02781623 · ClinicalTrials.gov registry record
Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 13
- Enrollment target
NCT02781623 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 13 participants.
The verdict
NCT02781623 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This study will quantify and examine the extent to which the quadriceps femoris muscle group atrophies following tibial plateau fractures and the length of time that atrophy affects function. The study will also look at the effects of tibial plateau fractures on the quadriceps muscle and the effect this atrophy has on functional outcome. Quadriceps atrophy will be measured both clinically and by using MRI scans taken pre-operatively, 3 months post operatively, and 1 year post-operatively. The injured leg and the non-injured leg will be scanned in order for the non-injured leg to serve as the control. In this way muscle volume can be estimated from the muscle thickness at specific locations in the thigh. The muscle strength of the quadriceps will also be assessed at the 3 month and 1 year visit by measuring isokinetic knee-extension torque, and functional assessment questionnaires will be completed at each study visit.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-10 |
| Est. Completion | 2022-01-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02781623
The ClinicalTrials.gov registry entry for NCT02781623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02781623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02781623 about?
NCT02781623 is a clinical study titled "Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture". This study will quantify and examine the extent to which the quadriceps femoris muscle group atrophies following tibial plateau fractures and the length of time that atrophy affects function. The study will also look at the effects of tibial plateau fractures on the quadriceps muscle and the effect ...
What is the current status of trial NCT02781623?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-10. Estimated completion is 2022-01-18.
What interventions are being tested in trial NCT02781623?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02781623?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.